logo

MTSR(Delisted)

MetseraยทNASDAQ
--
--(--)

MTSR Profile

Metsera, Inc.

A clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulating hormones

--
06/29/2022
01/31/2025
NASDAQ Stock Exchange
82
12-31
Common stock
3 World Trade Center, 175 Greenwich Street, New York, New York 10007
--
Metsera, Inc., was originally incorporated under the laws of the State of Delaware on June 29, 2022. The company is a clinical-stage biotechnology company developing next-generation injectable and oral trophic stimulating hormones, or NUSH, analog peptides, for the treatment of obesity, overweight and related diseases.